ResMed Overview
- Year Founded
-
1989
- Status
-
Public
- Employees
-
9,980
- Stock Symbol
-
RMD
- Investments
-
53
- Share Price
-
$212.91
- (As of Thursday Closing)
ResMed General Information
Description
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Contact Information
Website
www.resmed.comCorporate Office
- 9001 Spectrum Center Boulevard
- San Diego, CA 92123
- United States
Corporate Office
- 9001 Spectrum Center Boulevard
- San Diego, CA 92123
- United States
ResMed Stock Performance
As of 17-Apr-2025, ResMed’s stock price is $212.91. Its current market cap is $31.3B with 147M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $212.91 | $211.49 | $176.33 - $263.05 | $31.3B | 147M | 1.09M | $8.50 |
ResMed Financials Summary
As of 31-Dec-2024, ResMed has a trailing 12-month revenue of $4.93B.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 30-Jun-2024 | FY 2023 30-Jun-2023 | FY 2022 30-Jun-2022 |
|---|---|---|---|---|
| EV | 33,994,600 | 29,050,513 | 33,600,538 | 31,295,969 |
| Revenue | 4,926,773 | 4,685,297 | 4,222,993 | 3,578,127 |
| EBITDA | 1,773,365 | 1,526,715 | 1,346,605 | 1,176,636 |
| Net Income | 1,248,705 | 1,020,951 | 897,556 | 779,437 |
| Total Assets | 7,141,334 | 6,872,394 | 6,751,708 | 5,095,853 |
| Total Debt | 839,736 | 873,935 | 1,579,908 | 917,550 |
ResMed Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ResMed Comparisons
Industry
Financing
Details
ResMed Competitors (14)
One of ResMed’s 14 competitors is Inspire Medical Systems, a Formerly VC-backed company based in Golden Valley, MN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Inspire Medical Systems | Formerly VC-backed | Golden Valley, MN | ||||
| Nyxoah | Formerly VC-backed | Mont-Saint-Guibert, Belgium | ||||
| Philips | Corporation | Amsterdam, Netherlands | ||||
| Joerns Healthcare | Formerly PE-Backed | Charlotte, NC | ||||
| Medtronic | Corporation | Minneapolis, MN |
ResMed Patents
ResMed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025900797-A0 | Patient interface and/or components thereof | Pending | 14-Mar-2025 | ||
| AU-2025900685-A0 | Earpiece component for positioning and stabilising structure | Pending | 07-Mar-2025 | ||
| AU-2025900689-A0 | An eye mask | Pending | 07-Mar-2025 | ||
| AU-2025900578-A0 | An eye mask | Pending | 27-Feb-2025 | ||
| AU-2025900420-A0 | Headgear for patient interfaces | Pending | 14-Feb-2025 |
ResMed Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ResMed Investments & Acquisitions (53)
ResMed’s most recent deal was a Merger/Acquisition with Inhealthcare. The deal was made on 03-Jun-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Inhealthcare | 03-Jun-2024 | Merger/Acquisition | Clinics/Outpatient Services | ||
| Lenus Health | 02-Feb-2024 | Corporate | Other Healthcare Technology Systems | ||
| Noctrix Health | 16-Jan-2024 | Later Stage VC | Therapeutic Devices | ||
| Somnoware | 03-Jul-2023 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
| Nyxoah | 23-Mar-2023 | PIPE | Therapeutic Devices |
ResMed ESG
Risk Overview
Risk Rating
Updated June, 04, 2024
24.67 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,109
Rank
Percentile
Healthcare
Industry
of 587
Rank
Percentile
Medical Devices
Subindustry
of 198
Rank
Percentile
ResMed Exits (1)
ResMed’s most recent exit was on 10-Jan-2012 from Sova Pharmaceuticals. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Sova Pharmaceuticals | 10-Jan-2012 | Completed |
|
ResMed Affiliates
Subsidiaries (10)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Mementor | Leipzig, Germany | 2014 | |
| Inhealthcare | Harrogate, United Kingdom | 2012 | |
| Somnoware | Sunnyvale, CA | 2012 | |
| Propeller Health | Madison, WI | 2010 | |
| Brightree | Norcross, GA | 2005 |
ResMed FAQs
-
When was ResMed founded?
ResMed was founded in 1989.
-
Where is ResMed headquartered?
ResMed is headquartered in San Diego, CA.
-
What is the size of ResMed?
ResMed has 9,980 total employees.
-
What industry is ResMed in?
ResMed’s primary industry is Therapeutic Devices.
-
Is ResMed a private or public company?
ResMed is a Public company.
-
What is ResMed’s stock symbol?
The ticker symbol for ResMed is RMD.
-
What is the current stock price of ResMed?
As of 17-Apr-2025 the stock price of ResMed is $212.91.
-
What is the current market cap of ResMed?
The current market capitalization of ResMed is $31.3B.
-
What is ResMed’s current revenue?
The trailing twelve month revenue for ResMed is $4.93B.
-
Who are ResMed’s competitors?
Inspire Medical Systems, Nyxoah, Philips, Joerns Healthcare, and Medtronic are some of the 14 competitors of ResMed.
-
What is ResMed’s annual earnings per share (EPS)?
ResMed’s EPS for 12 months was $8.50.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
